Details for New Drug Application (NDA): 074638
✉ Email this page to a colleague
NDA 074638 describes IOPAMIDOL-300, which is a drug marketed by Abbvie, Cook Imaging, Fresenius Kabi Usa, and Hospira, and is included in seven NDAs. Additional details are available on the IOPAMIDOL-300 profile page.
The generic ingredient in IOPAMIDOL-300 is iopamidol. There are eleven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the iopamidol profile page.
The generic ingredient in IOPAMIDOL-300 is iopamidol. There are eleven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the iopamidol profile page.
Summary for 074638
| Tradename: | IOPAMIDOL-300 |
| Applicant: | Abbvie |
| Ingredient: | iopamidol |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 074638
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 61% | ||||
| Approval Date: | Apr 30, 1997 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
